Lista de obras - Marta Vives-Pi - Dominio Público Uruguay

ADVANTAGES OF USING A CELL SEPARATOR AND METRIZAMIDE GRADIENTS FOR HUMAN ISLET PURIFICATION1

artículo científico publicado en 1996

Anti-peripherin B lymphocytes are positively selected during diabetogenesis

artículo científico publicado en 2008

B-cell anergy induces a Th17 shift in a novel B lymphocyte transgenic NOD mouse model, the 116C-NOD mouse

artículo científico publicado en 2016

Biomarkers for diagnosis and monitoring of celiac disease.

artículo científico publicado en 2013

CD26/DPPIV inhibition alters the expression of immune response-related genes in the thymi of NOD mice.

artículo científico publicado en 2016

Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis.

artículo científico publicado en 2017

Characterisation of the NES2Y cell line and its use in the production of human glucose-responsive insulin producing (hGRIP) cell lines by cell-cell fusion

artículo científico publicado en 2009

Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells

artículo científico publicado en 2016

Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation by acute rejection cytokines

artículo científico publicado en 2010

ENDOTOXIN CONTAMINATION MAY BE RESPONSIBLE FOR THE UNEXPLAINED FAILURE OF HUMAN PANCREATIC ISLET TRANSPLANTATION1

artículo científico publicado en 1998

Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity.

artículo científico publicado en 2013

Endotoxin activity of collagenase and human islet transplantation

artículo científico publicado en 1997

Engraftment of islets obtained by collagenase and Liberase in diabetic rats: a comparative study

artículo científico publicado en 2001

Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells

artículo científico publicado en 2003

Expression of glutamic acid decarboxylase (GAD) in the α, β and δ cells of normal and diabetic pancreas: implications for the pathogenesis of type I diabetes

artículo científico publicado en 2008

Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes.

artículo científico publicado en 2009

Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery.

artículo científico publicado en 2010

HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules

artículo científico publicado en 1999

How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.

artículo científico publicado en 2015

IFN beta accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to beta cells in nondiabetes-prone mice.

artículo científico publicado en 2004

Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice

artículo científico publicado en 2013

Incretin hormones as immunomodulators of atherosclerosis.

artículo científico publicado en 2012

Innovative immunological strategies for type 1 diabetes

artículo científico publicado en 2015

Islet transplantation in seminal vesicles restores glycemia in diabetic rats: a preliminary study

artículo científico publicado en 2002

Islet-infiltrating B-cells in nonobese diabetic mice predominantly target nervous system elements.

artículo científico publicado en 2005

Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis

artículo científico publicado en 2017

Maternal microchimerism: friend or foe in type 1 diabetes?

artículo científico publicado en 2014

Maternal microchimerism: increased in the insulin positive compartment of type 1 diabetes pancreas but not in infiltrating immune cells or replicating islet cells.

artículo científico publicado en 2014

Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

artículo científico publicado en 2016

Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.

artículo científico publicado en 2008

Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile

artículo científico publicado en 1994

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death

scientific journal article

Peripherin is a relevant neuroendocrine autoantigen recognized by islet-infiltrating B lymphocytes

artículo científico publicado en 2007

Phenotype and Functional Characteristics of Islet-Infiltrating B-Cells Suggest the Existence of Immune Regulatory Mechanisms in Islet Milieu

artículo científico publicado en 2007

Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes

artículo científico publicado en 2019

Proteasome subunits, low‐molecular‐mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin‐dependent diabetes mellitus: implications for autoimmunity ⬇️

artículo científico publicado el 1 de agosto de 1997

Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: role of IFNbeta.

artículo científico publicado en 2006

Regenerating gene Iα is a biomarker for diagnosis and monitoring of celiac disease: a preliminary study

artículo científico publicado en 2011

Remission Phase in Paediatric Type 1 Diabetes: New Understanding and Emerging Biomarkers.

artículo científico publicado en 2017

Syngeneic islet transplantation into seminal vesicles of diabetic rats

artículo científico publicado en 2005

TCR bias of in vivo expanded T cells in pancreatic islets and spleen at the onset in human type 1 diabetes.

artículo científico publicado en 2011

The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells

artículo científico publicado en 2016

Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset

artículo científico publicado en 2015

Urinary levels of regenerating protein Iα do not differentiate celiac patients and healthy subjects.

artículo científico publicado en 2013

Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes

artículo científico publicado en 2015

What potential is there for liposomal-based nanotherapy for the treatment of Type 1 diabetes?

artículo científico publicado en 2015

Why are levels of maternal microchimerism higher in type 1 diabetes pancreas?

artículo científico publicado en 2010

Lista de obras de Marta Vives-Pi

ADVANTAGES OF USING A CELL SEPARATOR AND METRIZAMIDE GRADIENTS FOR HUMAN ISLET PURIFICATION1

Anti-peripherin B lymphocytes are positively selected during diabetogenesis

B-cell anergy induces a Th17 shift in a novel B lymphocyte transgenic NOD mouse model, the 116C-NOD mouse

Biomarkers for diagnosis and monitoring of celiac disease.

CD26/DPPIV inhibition alters the expression of immune response-related genes in the thymi of NOD mice.

Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis.

Characterisation of the NES2Y cell line and its use in the production of human glucose-responsive insulin producing (hGRIP) cell lines by cell-cell fusion

Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells

Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation by acute rejection cytokines

ENDOTOXIN CONTAMINATION MAY BE RESPONSIBLE FOR THE UNEXPLAINED FAILURE OF HUMAN PANCREATIC ISLET TRANSPLANTATION1

Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity.

Endotoxin activity of collagenase and human islet transplantation

Engraftment of islets obtained by collagenase and Liberase in diabetic rats: a comparative study

Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells

Expression of glutamic acid decarboxylase (GAD) in the α, β and δ cells of normal and diabetic pancreas: implications for the pathogenesis of type I diabetes

Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes.

Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery.

HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules

How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.

IFN beta accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to beta cells in nondiabetes-prone mice.

Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice

Incretin hormones as immunomodulators of atherosclerosis.

Innovative immunological strategies for type 1 diabetes

Islet transplantation in seminal vesicles restores glycemia in diabetic rats: a preliminary study

Islet-infiltrating B-cells in nonobese diabetic mice predominantly target nervous system elements.

Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis

Maternal microchimerism: friend or foe in type 1 diabetes?

Maternal microchimerism: increased in the insulin positive compartment of type 1 diabetes pancreas but not in infiltrating immune cells or replicating islet cells.

Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.

Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death

Peripherin is a relevant neuroendocrine autoantigen recognized by islet-infiltrating B lymphocytes

Phenotype and Functional Characteristics of Islet-Infiltrating B-Cells Suggest the Existence of Immune Regulatory Mechanisms in Islet Milieu

Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes

Proteasome subunits, low‐molecular‐mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin‐dependent diabetes mellitus: implications for autoimmunity ⬇️

Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: role of IFNbeta.

Regenerating gene Iα is a biomarker for diagnosis and monitoring of celiac disease: a preliminary study

Remission Phase in Paediatric Type 1 Diabetes: New Understanding and Emerging Biomarkers.

Syngeneic islet transplantation into seminal vesicles of diabetic rats

TCR bias of in vivo expanded T cells in pancreatic islets and spleen at the onset in human type 1 diabetes.

The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells

Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset

Urinary levels of regenerating protein Iα do not differentiate celiac patients and healthy subjects.

Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes

What potential is there for liposomal-based nanotherapy for the treatment of Type 1 diabetes?

Why are levels of maternal microchimerism higher in type 1 diabetes pancreas?